Preliminary evaluation of the ‘Living Well on Haemodialysis’ programme

Feasibility and acceptability trial of intervention materials based on Acceptance and Commitment Therapy for people receiving in-centre renal haemodialysis

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN10070371

Enrollment

Registered

2022-02-23

Start date

2022-02-01

Completion date

Unknown

Last updated

2023-10-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Improvement of quality of life among people with end-stage renal disease receiving in-centre haemodialysis Urological and Genital Diseases Chronic kidney disease, stage 5

Interventions

Single-group before-and-after study, with baseline (pre-intervention) measures, then a 4-week intervention programme, post-intervention measures and 4-week post-intervention follow-up. Talking part i

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Age over 18 years 2. Received in-centre dialysis for at least 90 days in the last 2 years 3. Able to converse in English

Exclusion criteria

Exclusion criteria: 1. Not able to use the intervention because of a medical condition, active infection or malignancy 2. Unable or unwilling to give informed consent 3. Unable to take part in online data collection because of technical limitations

Design outcomes

Primary

Measure	Time frame
Physical, mental and kidney disease-specific quality of life, measured using the Kidney Disease Quality of Life Short Form (KDQOLSF) at baseline, 4 weeks (post intervention) and 8 weeks (4-week post intervention follow-up)	—

Secondary

Measure	Time frame
1. Psychological flexibility measured using the Acceptance and Action Scale at baseline (pre-intervention), 4 weeks (post-intervention) and 8 weeks (4-week post-intervention follow-up) 2. Acceptance of illness measured using the Acceptance of Illness Scale at baseline, (pre-intervention), 4 weeks (post-intervention) and 8 weeks (4-week post-intervention follow-up) 3. Feasibility assessed by recording recruitment and retention, plus fidelity, adherence and adverse events during the intervention and post-intervention 4. Acceptability assessed by collecting direct evaluative feedback using ratings scales and free-text open response formats, plus a focus group, to assess how participants experienced the intervention at post-intervention	—

Measure

Time frame

1. Psychological flexibility measured using the Acceptance and Action Scale at baseline (pre-intervention), 4 weeks (post-intervention) and 8 weeks (4-week post-intervention follow-up) 2. Acceptance of illness measured using the Acceptance of Illness Scale at baseline, (pre-intervention), 4 weeks (post-intervention) and 8 weeks (4-week post-intervention follow-up) 3. Feasibility assessed by recording recruitment and retention, plus fidelity, adherence and adverse events during the intervention and post-intervention 4. Acceptability assessed by collecting direct evaluative feedback using ratings scales and free-text open response formats, plus a focus group, to assess how participants experienced the intervention at post-intervention

—

Countries

England, United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026